国产成人精品亚洲777,亚洲乱码日产精品一二三 ,国产99久久亚洲综合精品,欧美疯狂性受XXXXX喷水

Huaota Certified as Enterprise Research Institute By Science, Technology and Economy Commission of Pudong New District, Shanghai, China

Shanghai, 13 Jan 2021 – Shanghai Huaota Biopharmaceutical Co., Ltd (“Huaota”) today announced that it has been certificated by the Science, Technology and Economy Commission of Pudo...

Press Releases

IND of Project HB0025 Approved by FDA

FDA has approved recently the HB0025 project submitted by Huaota for clinical trials. HB0025 is the world's first FDA-approved clinical trial for a bispecific fusion protein tar...

Press Releases

Huaota Projects Won Multiple Prizes in “1st Science and Technology Festival" of Huahai Pharm

Linhai, Dec 4, 2020, the opening ceremony of Huahai Pharmaceutical’s "1st Science and Technology Festival" and the founding ceremony of Huahai Science and Technology Assoc...

Press Releases

FIH Completed in Study of HB0017 Conducted in New Zealand

Huaota's first oversea project HB0017 injection started phase I clinical trial and completed the first participant administration on October 20, 2020 successfullyThe HB0017 inje...

Press Releases

IND of HB002.1M for Three Indications Approved by NMPA

Huaota is pleased to announce that HB002.1M ophthalmic injection project independently developed by the company obtained IND issued by the National Medical Products Administration f...

Press Releases

IND of HOT-1030 Approved by NMPA

Huaota is pleased to announce that Project HOT-1030 has been recently approved for drug clinical trial by the National Medical Products Administration.HOT-1030 is a monoclonal antib...

Press Releases